Lataa...
Chimeric antigen receptor T-cell immunotherapy in breast cancer: development and challenges
Chimeric antigen receptor (CAR) T-cell therapy is an innovative form of immunotherapy wherein autologous T-cells are genetically modified to express chimeric receptors encoding an antigen-specific single-chain variable fragment and costimulatory molecules. Moreover, CAR T-cell therapy can only work...
Tallennettuna:
| Julkaisussa: | J Cancer |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Ivyspring International Publisher
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7797648/ https://ncbi.nlm.nih.gov/pubmed/33442419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.54095 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|